SEC 13F Intelligence

Tybourne Capital Management (Hk) Ltd / BCYC

Tybourne Capital Management (Hk) Ltd’s Bicycle Therapeutics PLC Position

Does Tybourne Capital Management (Hk) Ltd own Bicycle Therapeutics PLC (BCYC)? Not currently — the last reported position was 993.7K shares worth $7M in Q2 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$7M
Q2 2025
Shares
993.7K
% of Portfolio
+20.00%
Quarters Held
25
position exited

Position History BCYC

Reported value by quarter
Q2 ’19: $20MQ2 ’19Q3 ’19: $22MQ4 ’19: $18MQ1 ’20: $27MQ2 ’20: $31MQ2 ’20Q3 ’20: $37MQ4 ’20: $35MQ1 ’21: $58MQ2 ’21: $59MQ2 ’21Q3 ’21: $81MQ4 ’21: $125MQ1 ’22: $51MQ2 ’22: $19MQ2 ’22Q3 ’22: $24MQ4 ’22: $27MQ1 ’23: $30MQ2 ’23: $33MQ2 ’23Q3 ’23: $26MQ4 ’23: $30MQ1 ’24: $38MQ2 ’24: $31MQ2 ’24Q3 ’24: $32MQ4 ’24: $18MQ1 ’25: $5MQ2 ’25: $7MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025993.7K$7M+20.00%
Q1 2025576.3K$5M+20.77%
Q4 20241.27M$18M+4.46%
Q3 20241.39M$32M+8.85%
Q2 20241.51M$31M+6.21%
Q1 20241.55M$38M+6.58%
Q4 20231.65M$30M+4.45%
Q3 20231.28M$26M+3.60%
Q2 20231.28M$33M+3.54%
Q1 20231.41M$30M+3.02%
Q4 2022905.7K$27M+2.67%
Q3 20221.04M$24M+2.33%
Q2 20221.15M$19M+1.40%
Q1 20221.15M$51M+3.00%
Q4 20212.05M$125M+3.71%
Q3 20211.96M$81M+2.05%
Q2 20211.96M$59M+1.25%
Q1 20211.96M$58M+1.28%
Q4 20201.96M$35M+0.73%
Q3 20201.96M$37M+0.92%
Q2 20201.96M$31M+0.94%
Q1 20201.96M$27M+0.98%
Q4 20191.96M$18M+0.71%
Q3 20191.96M$22M+0.97%
Q2 20191.96M$20M+0.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tybourne Capital Management (Hk) Ltd’s full portfolio or all institutional holders of BCYC.